Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been well described; however, the bulk of the literature has focused on heart ...

These scripts and codes are under WTFPL verion 2 license, a GPL-campatible free license. The modification version of RELION is under the same license of RELION, which is GPL ver.2. Please cite our ...

Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 ...